|
Литература к главе 5
1372. Abrahamson S., Bender M. A., Conger A. D., WolffS. (1973). Uniformity of radiation induced mutation rates among different species, Nature, 245, 460-462.
1373. Altland K., Kaempfer M., Forssbohm M., Werner W (1982). Monitoring for changing mutation rates using blood samples submitted for PKU screeninG. In: Human Genetics, Part A, The unfolding genome, A Liss, New York, pp. 277-287.
1374. Ames B. N., McCann J., Yamasaki E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test, Mutation Res., 31, 347-364.
1375. Anonymous (1982). Identifying and estimating the genetic impact of chemical environmental mutagens. The National Academy Press, Washington.
1376. Anonymous (1983). International Commission for Protection against environmental mutagens and carcinogens, Committee 4 report, Mutation Res., 115, 255-291.
1377. Anonymous (1982). Ionizing radiation: Sources and biological effects, United Nations Scientific Committee on the Effects of Atomic Radiation, United Nations, New York.
1378. Atwood К. С., Scheinberg S. L. (1958). Somatic variation in human erythrocyte antigens, Sympos. Genet. Approches on Somatic Cell Variation, Gatlinburg, April 2-5, 1958, J. of Cellular and Comparative Physiology, Vol. 52, Suppl. 1, pp. 97-123.
1379. AuerbachC., RobsonJ.M. (1946). Chemical production of mutations, Nature, 157, 302.
1380. Balaban G., Gilbert F., Nichols W., Madans А. Т., Shields J. (1982). Abnormalities of chromosome No. 13 in retinoblastomas from individuals with normal constitutional karyotype, Cancer Genet. Cytogenet., 6, 213-221.
1381. Barcinski M. A., Abreu M. C., de Almeida J. C. C., Naya J. M., Fonseca L. G., Castro L. E. (1975). Cytogenetic investigation in a Brazilian population living in an area of high natural radioactivity, Am. J. Hum. Genet, 27, 802-806.
1382. Barker D., Schafer M., White R. (1984). Restriction sites containing CpG show a higher frequency of polymorphism in human DNA, Cell, 36, 131-138.
1383. Barthelmess A. (1956). Mutagene Arzneimittel, Arzneimittelforsch, 6, 157.
1384. Barthelmess A. (1970). Mutagenic substances in the human environment. In: Vogel F., Rohrborn G. (eds.), Chemical mutagenesis in mammals and man, Springer, Berlin, Heidelberg, New York, pp. 69-147.
1385. Barthelmess A. (1973). Erbgefahren im Zivili-sationsmilieu, Goldmann, Munchen.
1386. Bartsch H. D. (1970). Virusinduced chromosome alterations in mammals and man. In: Vogel F, Rohrborn G. (eds.), Chemical Mutagenesis in Mammals and Man, Springer Verlag, Berlin, Heidelberg, New York, pp. 420-432.
1386a. Basler A., Buselmaier D., Rohrborn G. (1976). Elimination of spontaneous and chemically induced chromosome aberrations in mice during early embryogenesis, Hum. Genet, 33, 121-130.
1387. Bauchinger M. (1968). Chromosomenaberrationen und ihre zeitliche Veranderungen nach Radium-Rontgentherapie gynakologischer Tumoren, Strahlentherapie, 135, 553-564.
1388. Behnke H., Holtermann W. (1961). Haufigkeit, Vererbung und klinische Auspragung der Aniridie in Schleswig-Holstein, Proceedings of the 2nd International Congress, Roma, pp. 1879-1883.
1389. Benedict W. F., Murphree A. L., Banerjee A., Spina C. A., Sparkes M. C., Sparkes R. S. (1983). Patient with 13 chromosome deletion: Evidence that the retinoblastoma gene is a recessive cancer gene, Science, 219, 973-975.
1390. Benzer S. (1957). The elementary units of heredity. In: McElroy W, Glass B. (eds.), The chemical basis of the redity, pp. 70-93, Johns Hopkins University press, Baltimore.
1391. Berendes U. (1974). Multiple tumors of the skin: Clinical, histopathological, and genetic features, Hum. Genet, 22, 181-210.
1392. Berg K. (ed.) (1979). Genetic damage in man caused by environmental agents, Academic Press, New York, etc.
1393. Bizzozero O. J., Johnson K. G., Ciocco A. (1966). Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964, New Engl. J. Med, 274, 1095.
1394. Blank С. (1960). Apert's syndrome (A type of
acrocephalosyndactyly), Observations on a British series of 39 cases, Ann. Hum. Genet, 24, 151-164.
1395. Bloom A. B. (1972). Induced chromosome aberrations in man, Adv. Hum. Genet., 3, 99-172.
1396. Bochkov N. P., Lopukhin Y. M., Kulsehov N. P., Kovalchuk L. V. (1974). Cytogenetic study of patients with ataxiateleangiectasia, Hum. Genet., 24, 115-128.
1397. Bora K. G., Douglas G. R., NestmannE.R. (eds.), (1982). Chemical mutagenesis, human population monitoring and genetic risk assessment, Progr. in Mut. Res., Vol. 3, Elsevier, Amsterdam.
1398. Borberg A. (195i). Clinical and genetic Investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis, Munksgaard, Copenhagen.
1399. Воue А., Воue J. (1973). Etudes chromosomiques et anatomiques des grosseuses suivant l'arret de contraceptifs steroides, J. Gynecol. Obstet. Biol. Reprod. (Paris), 2, 141-154.
1400. Brewen J. G., Luippold H.E. (1971). Radiationinduced human chromosome aberrations. In vitro doserate studies, Mutat. Res., 12, 305-314.
1401. Brewen J. G., Preston R. J. (1974). Cytogenetic effects of environmental mutagens in mammalian cells and the extrapolation to man, Mutat. Res., 26, 297-305.
1402. Briard-GuUlemot M. L., Bonaiti-Pellie C., Feingold Т., Frezal T. (1974). Etude genetique de retinoblastome, Hum. Genet., 24, 271.
1403. Brook J. D., Gosden R. G., Chandley A.C. (1984). Maternal ageing and aneuploid embryosevidence from the mouse that biological and notchronological age is important influence, Hum. Genet., 66, 41-45.
1404. Bucher K., loanescu V., Hansen J. (1980). Frequency of new mutants among boys with Duchenne muscular dystrophy, Am. J. Med. Genet., 7, 27-34.
1405. Bundey S. (1981). A genetic study of Duchenne muscular dystrophy in the West Midlands, J. of Med. Genet., 18, 1-7.
1406. Bundey S. (1982). Clinical evidence for heterogeneity in myotonic dystrophy, J. Med. Genet., 19, 341-348.
1407. Burhorn D. (1970). Klinischgenetische Analyse des von Hippel-Lindau-Syndroms, ausgehend von Patienten mit Angiomatosis retinae, MD Dissertation University of HeidelberG.
1408. Burnet M. (1974). The biology of cancer. In: Chromosomes and cancer German. J. (ed.), Wiley and Sons, New York, London, Sidney, Toronto.
1409. Burnet F. M. (1974). Intrinsic mutagenesis: A genetic approach to ageing, Wiley and Sons, New York.
1410. Carothers A. D., Collyer S., DeMey R., Johnston I. (1984). An aetiological study of 290 XXY males, with special reference to the role of paternal age, Hum. Genet., 68, 248-253.
1411. Carr D. H. (1967). Chromosomes after oral contraceptives, Lancet, II, 830-831.
1412. Carter C. O. (1977). Monogenic disorders, J. Med. Genet, 14, 316-320.
1413. Caskey С. Т., Nussbaum R. L., Cohan L. C., Pollack L. (1980). Sporadic occurrence of Duchenne muscular dystrophy. Evidence for a new mutation, Clin. Genet., 18, 329-341.
1414. Cavenee W. K., DryjaT.P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. (1983). Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature, 305, 779-784.
1416. Chen Dequing et al. (1982). Cytogenetic investigation in a population living in the high background radiation area, Chin. J. of Radiology Med. and Protection, 2, 61-63.
1417. ChOds J. D. (1981). The effect of a change in mutation rate on the incidence of dominant and X-linked recessive disorders in man, Mutation Res., 83, 145-158.
1418. Chu E. H. Y, Powell S. S. (1976). Selective systems in somatic cell genetics, Adv. Hum. Genet., 7, 189-258.
1419. Clarke A. M. (1967). Caffeine- and amino acid-effects upon try+ revertant yield in UV-irradiated hor+ and hor- mutants of E. coli B/r, Mol. Gen. Genet, 99, 97-108.
1420. Cleaver J. E. (1972). Xeroderma pigmentosum. Variants with normal DNA repair and normal sensitivity to ultraviolet light, J. Invest. Dermatol., 58, 124-128.
1421. Cleaver J. E., Bootsma D. (1975). Xeroderma pigmentosum: Biochemical and genetic characteristics, Ann. Rev. Genet., 9, 19-38.
1422. Conen P. E., Lansky G. S. (1961). Chromosome damage during nitrogen mustard therapy, Br. Med. J., I, 1055-1057.
1423. Croce С. С. (1985). Chromosomal translocations, oncogenes, and B-cell tumors, Hosp. Pract, 20, 41-48.
1424. Croce С. М., Klein G. (1985). Chromosome translocations and human cancer, Sci. Am., 252, 54-60.
1425. Crow J. F. (1983). Chemical mutagen testing: Acommittee report, Environmental Mutagenesis, 5, 255-261.
1426. Crowe F. W., Schull W. J., Neel J. V. (1956). A clinical, pathological, and genetic study of multiple neurofibromatosis, Thomas, Springfield.
1427. Cui Yanwei (1982). Heredity diseases and congenital malformation survey in high background radiation area, Chinese J. of Radiol. Med and Protection, 2, 55-57.
1428. Curtis D. (1974). Acrocentric association in Mongol populations, Hum. Genet., 22, 17-22.
1429. Danforth G. H. (1921). The frequency of mutation and the incidence of hereditary traits in man. Eugenics, genetics and the family, Scientific Papers of the 2nd International Congress of Eugenics, Vol. I, New York, pp. 120-128.
1430. Danieli G. A., Barbujani G. (1984). Duchenne muscular dystrophy. Frequency of sporadic cases, Hum. Genet., 67, 252-256.
1431. Danieli G. A., Mostacciuolo M. L., Pilotto G., Angelini C., Bonfante A. (1980). Duchenne muscular dystrophy. Data from family studies, Hum. Genet., 54, 63-68.
1432. Davie A. M., Emery A. E. H. (1978). Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy, J. Med. Genet, 15, 339-345.
1433. Davies K. E., Harper K., Bonthron D., Krumlauf R., Polkey A., Pembrey M.W., Williamson R. (1984). Use of a chromosome 21 cloned DNA probe for the analysis of nondisjunction in Down Syndrome, Hum. Genet., 66, 54-56.
1434. DeGroot L.J., Paloyan E. (1973). Thyroid carcinoma and radiation. A Chicago endemiC., J. Am. Med. AssoC., 225, 487-491.
1435. Demerec M. (1937). Frequency of spontaneous mutations in certain stocks of Drosophila melanogaster, Genetics, 22, 469.
1436. Deng Shaozhuang et al. (1982). Birth survey in high background radiation area, Chin. J. Radiol. Med. Protection, 2, 60.
1437. Deuel T. F., Huang J. S. (1984). Roles of growth factor activities in oncogenesis, Blood, 64, 951-958.
1438. Dhadial R. K Machim A. M., Tail S. M. (1970). Chromosomal anomalies in spontaneously aborted human fetuses, Lancet, II, 20-21.
1439. Drake J. W. (ed.) (1973). Proceedings of an International Workshop on the Genetic Control of Mutation, Genetics [Suppl.], 73.
1439a. Duckworth-Rysiecki G., Cornish K., Clarke С. А., Buchwald M. (1985). Identification of two complementation groups in Fanconi anemia, Somatic Cell and Mol. Genet, 11, 35-41.
1440. Ehling U. H (1982). Risk estimate based on germ cell mutations in mice. In: Sugimura T, Kondo S, Takebe H. (eds.), Environmental mutagens and carcinogens, Proc. 3rd Intern. Conf. on Environmental Mutagens, Univ. of Tokyo Press. Tokyo and A. Liss, New York, pp. 709-719.
1441. Ek J. (1959). Thyroid function in mothers of mongoloid infants, Acta Paediatr, 48, 33-42.
1442. Epstein С J., Martin G. M., Schultz A.L., Motulsky A. G. (1966). Werner's syndrome: A review of its symptomatology. Natural history, pathological features, genetics and relationship to the natural aging process, Medicine, 45, 177-221.
1443. Erickson J.D. (1979). Paternal age and Down syndrome, Amer. J. Hum. Genet, 31, 489-497.
1444. Erickson J. D., Bjerkedal T. (1981). Down syndrome associated with father's age in Norway, J. of Med. Genet, 18, 22-28.
1445. Evans J. A., Hunter A. G. W, Hamerton J.L. (1978). Down syndrome and recent geographic trends in Manitoba, J. Med. Genet, 15, 43-47.
1446. Ferguson-Smith M. A., Handmaker S.D. (1961). Observations on the satellited human chromosomes, Lancet, I, 638-640.
1447. Fialkow P. J. (1967). Autoantibodies and chromosomal aberration, Lancet, I, 1106.
1448. Fialkow P.J. (1967). Thyroid antibodies, Down's syndrome and maternal age, Nature, 214, 1253-1254.
1449. Fialkow P.J. (1977). Clonal origin and stem cell evolution of human tumors. In: Genetics of Human Cancer, Mulvihill J. J, Miller R. W, Fraumeni J. F. Jr (eds.), Raven, New York, pp. 439-453.
1450. Fischer E., Thielmann H. W, Neundorfer В., Rentsch F. J., Edler L., Jung E.G. (1982). Xeroderma pigmentosum patients from Germany: Clinical symptoms and DNA repair characteristics, Arch. Dermatol. Res, 274, 229-247.
1451. Fitzgerald P. H, Stewart J., Suckling R. D. (1983). Retinoblastoma mutation rate in New Zealand and support for the twohit model, Hum. Genet, 64, 128-130.
1452. Ford C. E. (1970). Cytogenetics and sex determination in man and mammals, J. Biosoc. Sci. [Suppl.], 2, 7-30.
1453. Ford С. Е., Evans E. P., Searle A. G. (1978). Failure of irradiation to induce Robertsonian translocations in germ cells of male mice. In: Conference on Mutations: Their origin, nature and potential relevance to genetic risk in man, Jahreskonferenz 1977, Zentrallaboratorium fur Mutagenitatsprafungen, H. Boldt Verlag, Boppard, pp. 102-108.
1454. Ford С. E., Searle A. G., Evans E. P., West B. J. (1969). Differential transmission of translocations induced in spermatogonia of mice by X-irradiation, Cytogenetics, 8, 447-470.
1455. Francke U., Benirschke K., Jones O. W. (1975). Prenatal diagnosis of trisomy 9, Hum. Genet, 29, 243-250.
1456. Francke U., Felsenstein J., Gartler S.M., Migeon B. R., Dancis J., Seegmiller J. E., Bakay F., Nyhan W.L. (1976). The occurence of new mutants in the X-linked recessive Lesch-Nyhan disease, Am. J. Hum. Genet, 28, 123-137.
1457. Freese E. (1963). Molecular mechanism of mutations. In: Molecular genetics, Taylor J. H. (ed.), Plenum, New York, pp. 207-269.
1458. Freese E. (1971). Molecular mechanisms of mutations. In: Chemical mutagens, Hollaender A. (ed.), Vol. 1, Plenum, New York, pp. 1-56.
1459. Fulder S. J., Holliday R. (1975). A rapid rise in cell variants during the senescence of populations of human fibroblasts, Cell, 6, 67-73.
1460. Gardner R. J. M. (1977). A new estimate of the achondroplasia mutation rate, Clin. Genet, 11, 31-38.
1461. Gebhardt E. (1974). Antimutagens, Data and problems (review), Hum. Genet, 24, 1-32.
1462. Gebhart E. (1981). Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing, Hum. Genet, 58, 235-254.
1463. Geissler E., Theile M. (1983). Virusinduced gene mutations of eukaryotic cells, Hum. Genet, 63, 1-12.
1464. German J. (ed.). (1983). Chromosome mutation and neoplasia, AR Liss, New York.
1465. German J. (1983). Neoplasia and chromosome-breakage syndromes. In: Chromosome mutation and neoplasia, German J. (ed.), AR Liss, New York, pp. 97-134.
1466. German J., Bloom D., Archibald R. (1965). Chromosome breakage in a rare and probably genetically determined syndrome of man, Science, 148, 506-507.
1467. Gilbert F. (1983). Retinoblastoma and recessive alleles in tumorigenesis, Nature, 305, 761-762.
1468. Glatt H., Oesch F. (1984). Variations in epoxide hydrolast activities in human liver and blood. In: С. Н. S. Banbury Report 16, Genetic Variability in Responses to Chemical Exposure, OmennG. S., Gelboin H.V. (eds.), Cold Spring Harbor Laboratory, pp. 189-201.
1469. Gropp A., Flatz G. (1967). Chromosome breakage and blastic transformation of lymphocytes in ataxiateleangiectasia, Hum. Genet., 5, 77-79.
1470. Gruneberg H. (1970). Das Problem der MutationsbelastunG. In: Genetic and Geselschaft Wendt G. G. (ed.), Wissenschaftliche Verlagsanstalt, Stuttgart, pp. 72-77.
1471. Gunther M., PenroseL.S. (1935). The genetics of epiloia, J. Genet, 34, 413-430.
1472. Haldane J. B. S. (1935). The rate of spontaneous mutation of a human gene, J. Genet., 31, 317-326.
1473. Haldane J. B. S. (1939). The spread of harmful autosomal recessive genes in human populations, Ann. Eugen, 9, 232-237.
1474. Haldane J. B. S. (1947). The mutation rate of the gene for hemophilia, and its segregation ration in males and females, Ann. Eugen, 13, 262-271.
1475. Hansemann D. von (1890). Uber asymetrische Zellteilung in Epithelkrebsen und deren biologische Bedeutung, Virchow's Arch. Pathol. Anat, 119, 299-326.
1476. Hansteen I.-L., Varslot K., Steen-Johnsen J., hangard S. (1982). Cytogenetic screening of a newborn population, Clin. Genet., 21, 309-314.
1477. Harnden D. G. (1974). Ataxia teleangiectasia syndrome: Cytogenetic and cancer aspects. In: Chromosomes and cancer, German J. (ed.), Raven, New York, pp. 87-104.
1478. Harnden D. G. (1977). Cytogenetics of human neoplasia. In: Genetics of human cancer, Mulvihill J. J., Miller R. W., Fraumeni J. F. Jr. (eds.), Raven, New York, pp. 87-104.
1479. Harnden D. G. (1974). Viruses, chromosomes, and tumors: The interaction between viruses and chromosomes. In: German J. (ed.), Chromosomes and Cancer, J. Wiley and Sons, New York, pp. 151-190.
1480. Hassold Т., Jacobs P., Kline J., Stein Z., Warburton D. (1981). Effect of maternal age on autosomal trisomies, Ann. Hum. Genet., 44, 29-36.
1481. Hassold T. J., Jacobs P. A. (1984). Trisomy in man, Ann. Rev. Genet., 18, 69-77.
1482. Hayes A., Costa Т., Scriver С R., Childs B.
(1985). The effect of Mendelian disease on human health. II. Response to treatment, Am. J. Med. Genet., 21, 243-255.
1483. Hayflik L. (1965). The limited in vitro lifetime of diploid cell strains, Exp. Cell. Res., 37, 614-636.
1484. Hayflik L., Moorhead P. S. (1961). The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585-621.
1485. Hecht D., Kaiser McCaw B. (1977). Chromosome instability syndromes. In: Genetics of human cancer, Milvihill J. J., Miller R. W., Fraumeni J. F. (eds.), Raven, New York, pp. 105-123.
1486. Herrmann J. (1966). Der Einfluss des Zeugungsalters auf die Mutation zu Hamophilie A., Hum. Genet, 3, 1-16.
1487. High Background Radiation Research Group, China (1980). Health survey in high background radiation area in China, Science, 209, 877-880.
1488. Hirschhorn K. (1968). Cytogenetic alterations in leukemia. In: Perspectives in leukemia, Dameshek W., Dutcher R. M. (eds.), Grune and Stratton, New York, pp. 113-122.
1489. Hollaender A. (ed.) (1973). Chemical mutagens. Principles and methods for their detection, Plenum, New York, Vol. I/II 1971; Vol. Ill, 1973.
1490. Holliday R., Kirkwood Т. В. L. (1981). Predictions of the somatic mutation and mortalisation theories of cellular ageing are contrary to experimental observations, J. Theor. Biol., 93, 627-642.
1491. Hook E. B. (1981). Unbalanced Robertsonian translocations associated with Down's syndrome or Patau's syndrome: Chromosome subtype, proportion inherited, mutation rates and sex ratio, Hum. Genet., 59, 235-239.
1492. Hook E. B., Cross P. K. (1981). Temporal increase in the rate of Down syndrome livebriths to older mothers in New York State, J. Med. Genet, 18, 29-30.
1493. Hook E. B., Cross P. K. (1982). Paternal age and Down's syndrome genotype diagnosed prenatally: No association in New York State data, Hum. Genet, 62, 167-174.
1494. Hook E. В., Cross P. K., Regal R. R. (1984). The frequency of 47, +21,47, +18 and 47, + 13 at the uppermost extremes of maternal ages: results on 56094 fetuses studied prenatally and comparisons with data on livebirths, Hum. Genet, 68, 211-220.
1495. Hook E. В., Regal R. R. (1984). A search for a paternal age-effect upon cases of 47, +21 in which the extra chromosome is of paternal origin, Am. J. Hum. Genet., 36, 413-421.
1496. Hook E. B., Schreinemachers D. M., WUley A. M., Cross P. K. (1983). Rates of mutant structural chromosome rearrangements in human fetuses: Data from prenatal cytogenetic studies and associations with maternal age and parental mutagen exposure, Amer. J. Hum. Genet, 35, 96-109.
1497. Ishimaru Т., Cihak R. W., Land C. E., Steer A., Yamada A. (1975). Lung cancer at autopsy in A-bomb survivors and controls, Hiroshima and Nagasaki, 1961-1970. II. Smoking, occuration and A-bomb exposure, Cancer, 36, 1723-1728.
1498. luchi I. (1968). Abnormal hemoglobin in Japan: Biochemical and epidemiologic characters of abnormal hemoglobin in Japan, Acta Haematol., Jpn., 31, 842-851.
1499. Jablon S., Kato H. (1970). Childhood cancer in relation to prenatal exposure to A-bomb radiation, Lancet, II, 1000.
1500. Jacobs P. A. (1981). Mutation rates of structural chromosome rearrangements in man, Amer. J. Hum. Genet., 33, 44-45.
1501. Jacobs P. A., Frakiewitz A., Law P. (1972). Incidence and mutation rates of structural rearrangements of the autosomes in man, Ann. Hum. Genet, 35, 301-319.
1502. Jacobs P. A., Funkhauser J., Matsuura J. (1981). In: Hook E.B., Porter I.H. (eds.), Population and biological aspects of human mutation, Academic Press, New York, London, pp. 133-145.
1503. Jacob P. A., Mayer M. (1981). The origin of human trisomy: A study of heteromorphisms and satellite associations, Ann. Hum. Genet., 45, 357-365.
1504. Jacobs P. A., Morton N. E. (1977). Origin of human trisomies and polyploids, Hum. Hered., 27, 59-72.
1505. Janerich D. Т., Flink E. M., Keogh M.D. (1976). Down's syndrome and oral contraceptive usage, Br. J. Obstet. Gynaecol, 83, 617-620.
1506. Jones K. L., Smith D. W., Hervey M. A. S., Hall B. D., QuanL. (1975). Older paternal age and fresh gene mutation: Data on additional disorders, J. Pediatr., 86, 84-88.
1507. Jongbloet P. H., Mulder A., Hamers A. J. (1982). Seasonality of preovulatory nondisjunction and the aetiology of Down syndrome, A European collaborative study, Hum. Genet, 62, 134-138.
1508. Kemp T. (1940). Altern and Lebensdauer. In: Handbuch der Erbbiologie des Menschen, Just G. (ed.), Springer Verlag, Berlin, pp. 408-421.
1509. Kerr С. В. (1965). Genetics of human blood coagulation, J. Med. Genet, 2, 254.
1510. Kimura M. (1968). Evolutionary rate at the molecular level, Nature, 217, 624-626.
1511. Kimura M., Ohta T. (1973). Mutation and evolution at the molecular level, Genetics [Suppl.], 73, 19-35.
1512. King J. L. (1971). The role of mutation in evolution, Proceedings of the 6th Berkeley Symposium on Mathematical Statistics and Probability, University of California Press, Berkeley, pp. 69-100.
1513. Kirkwood T. B. L., Cremer Th. (1982). Cytogerontology since 1881: A reappraisal of August Weisman and a review of modern progress, Hum. Genet, 60, 101-121.
1514. Klamerth O. L. (1976). Inhibition of transcription by isonicotinic and hydrazide, Mutat. Res., 35, 53-64.
1515. Klamerth O. L. (1978). Inhibition of postreplication repair by isonicotinic and hydrazide, Mutat. Res., 50, 251-261.
1516. Klose J. (1975). Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissue, Hum. Genet, 26, 231-243.
1517. Klose J., Blohm J., Gerner I. (1977). The use of isoelectric focusing and electrophoresis to obtain highly complex-protein patterns of mouse embryos. In: Methods in prenatal toxicology, Neubert D., Merker H.-J., Kwasrigroch T. E. (eds.), Thieme, Stuttgart, pp. 303-313.
1518. Knudson A. G. (1971). Mutation and cancer: Statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA, 68, 820-823.
1519. Knudson A. G. (1973). Mutation and human cancer, Adv. Cane. Res., 17, 317-352.
1520. Knudson A. G. (1977). Genetics and etiology of human cancer, Adv. Hum. Genet., 8, 1-66.
1521. Knudson A. G., Hethcote H. W., Brown B. W. (1975). Mutation and childhood cancer. A probabilistic model for the incidence of retinoblastoma, Proc. Natl. Acad. Sci. USA, 72, 5116-5120.
1522. Knudson A. G., Strong L. С. (1972). Mutation and cancer: Neuroblastoma and pheochromocytoma, Am. J. Hum. Genet., 24, 514-532.
1523. Kochupillai N., Verma J. C., Grewal M. S., Ramalingaswami V. (1976). Down's syndrome and related abnormalities in an area of high background radiation in coastal Kerala, Nature, 262, 60-61.
1524. Kondo S. (1973). Evidence that mutations are induced by error in repair and replication. In: Workshop on the Genetic Control of Mutation, Genetics [Suppl.], 73, 109-122.
1525. Koufos A., Hansen M. F., Copeland N. G., Jenkins N. A., Lampkin B. C., Cavenee W. K. (1985). Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism, Nature, 316, 330-334.
1526. Langenbeck U., Hansmann L, Hinney В., Honig V. (1976). On the origin of the supernumerary chromosome in autosomal trisomieswith special reference to Down's Syndrome, Hum. Genet, 33, 89-102.
1527. Lawry R. В., Jones D. C., Renwick D. H. G., Trimble B.K. (1976). Down syndrome in British Columbia, 1972-1973: Incidence and mean maternal age, Teratology, 14, 29-34.
1528. Lea D. E., Catcheside D. G. (1942). The mechanism of the induction by radiation of chromosomes aberrations in Tradescantia, J. Genet., 44, 216-245.
1529. LeBeau M., Rowley J. D. (1984). Heritable fragile sites in cancer, Nature, 308, 607-608.
1530. Lejeune J., Turpin R., Rethore M.O. (1960). Les enfants nes de parents irradies (Cas particuliers de la sex-ratio), 9th International Congress Radiology, 23.-30.7, 1959, Munchen, pp. 1089-1096.
1531. Lele K. P., Penrose L. S., Stallard H. B. (1963). Chromosome deletion in a case of retinoblastoma, Ann. Hum. Genet., 27, 171.
1532. Lenz W. (1959). Die Abhangigkeit der Missbildungen vom Alter der Eltern, Verb. Dtsch. Ges. Inn. Med., 64, Kongr. Bergmann Verlag, Munchen, pp. 74-88.
1533. Lindgren D. (1972). The temperature influence on the spontaneous mutation rate. I. Literature review, Hereditas, 70, 165-178.
1534. Lindsten J., Marsk L., Berglund K., Iselius L., Ryman N.. Anneren G., Kjessler В., Mitelman F., Nordenson I., Wahlstrom J., Vejlens L. (1981). Incidence of Down's syndrome in Sweden during the years 1968-1977. In: Burgio et al. (eds.), Trisomy 21, Springer, Berlin, Heidelberg, New York, pp. 195-210.
1535. Lu Bingxin et al. (1982). Survey of hereditary ophthalmopathies and congenital ophthalmic malformations in high background areas, Chin. J. Radiol. Med. and Protection, 2, 58-59.
1536. Liiers H. (1955). Zur Frage der Erbschadigung durch tumortherapeutische Cytostatica, Z. Krebsforsch., 60, 528.
1537. Liming K. G., Searle A. G. (1970). Estimates of the genetic risks from ionising irradiation, Mutation Res., 12, 291-304.
1538. Luria S. E., Delbruck M. (1943). Mutations of bacteria fron virus sensitivity to virus resistance, Genetics, 28, 491.
1539. Lynas M. A. (1956/57). Dystrophia myotonica with special reference to Northern Ireland, Ann. Hum. Genet., 21, 318-351.
1540. Lynch H. T. (1976). Miscellaneous problems, cancer and genetics. In: Lynch H. T. (ed.), Cancer genetics, Thomas, Springfield.
1541. Lyon M. F., Philipps R. J. S. (1975). Specific locus mutation rates after repeated small radiation doses to mouse oocytes, Mutation Res., 30, 375-382.
1542. Mackenzie H. J., Penrose L. S. (1951). Two pedigrees of ectodactyly, Ann. Eugen, 16, 88.
1543. Magenis R. E., Overton K. N., Chamberlin J., Brady Т., Lovrien E. (1977). Parental origin of the extra chromosome in Down's syndrome, Hum. Genet, 37, 7-16.
1544. Mailing H. V., DeSerres F. J. (1973). Genetic alternations at the molecular level in X-ray induced ad-3B mutants of Neurospora crassa, Radiat. Res., 53, 77-87.
1545. Mark J. (1974). Cytogenetics of the human meningioma. In: German J. (ed). Chromosomes and cancer, J. Wiley and Sons, New York, pp. 497-517.
1546. Marsden C. D. (1982). Neurotransmitters and CNS disease: Basal ganglia disease, The Lancet, II, 1141-1146.
1547. Martin С. М., Sprague С. A., Epstein C. J. (1970). Replicative lifespan of cultivated human cells: Effect of donor's age, tissue and genotype, Lab. Invest., 23, 86-92.
1548. Matsunaga E. (1976). Hereditary retinoblastoma: Penetrance, expressivity and age of onset, Hum. Genet, 33, 1-15.
1549. Matsunaga E. (1981). Genetics of Wilm's tumor, Hum. Genet, 57, 231-246.
1550. Matsunaga E., Tonomura A., Oishi H., Kikuchi Y. (1978). Reexamination of paternal age effect in Down's syndrome, Hum. Genet., 40, 259-268.
1551. Mattel J. F., Mattel M.G., Ayme S., Siraud F. (1979). Origin of the extra chromosome in trisomy 21, Hum. Genet. 46, 107-110.
1552. Mavor J. W. (1924). The production of nondisjunction by X-rays, J. Exp. Zool., 39, 381-432.
1553. McCannJ., Ames B.N. (1976). Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals, Discussion, Proc. Natl. Acad. Sci. USA, 73, 950 954.
1554. McCann J., Choi E., Yamasaki E., Ames B.N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals, Proc. Natl. Acad. Sci. USA, 72, 5133-5139.
1555. McGregor D. H., et al. (1977). Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1969, J. Natl. Cancer Inst, 59, 799-811.
1556. Mikkelsen M., Fischer G., Stene J., Petersen E. (1976). Incidence study of Down's syndrome in C |